Investors want companies to sharpen their equity story and clarify the value of their sustainability initiatives. Here’s what company leaders can do.
Alex Monnard’s Post
More Relevant Posts
-
The chief of staff role has been growing in importance and popularity as the pressure on private and public sector leaders intensifies. To develop an empirical picture of the role, we analyzed publicly available data on approximately 250 chiefs of staff who have served in the role within the past eight years. The group is almost evenly split between men and women, and its members have worked at roughly 300 organizations around the world. Our analysis suggests that COS career trajectories and responsibilities vary widely, but eight broad archetypes emerge. https://lnkd.in/eVuh55ki
To view or add a comment, sign in
-
I’m thrilled to invite you to our 6th Annual McKinsey Cancer Center Symposium at #ESMO2024! Join us on September 13th for a virtual session about current trends in oncology and paths to success in light of today’s market conditions. Our 2024 symposium will be hosted in a dynamic digital format, allowing you to participate virtually from anywhere in the world and take part in the discussion. Don’t miss out on this opportunity to engage with leading experts and be part of the conversation! For more details and to secure your spot, please click here: https://lnkd.in/eXqHqHrR. I am looking forward to seeing you there! #ESMO #Cancer #Oncology
To view or add a comment, sign in
-
Excited to share McKinsey’s latest report on the European biotech financing landscape based on our presentation at Bio€quity Europe 2024 a few weeks back. My key takeaway from the report? The biotech industry started 2024 with some positive trends on financing and these trends are bringing a sentiment of cautious optimism to both biotech companies and investors. Check out the infographic below for other key takeaways and read the report for more strategic implications and insights for investors and biotech companies alike: https://lnkd.in/eMJkZJ2z #Biotech #BiotechInvestments #FutureOfBiotech #BioEquity
To view or add a comment, sign in
-
What does #productivity measure, and why is it important? What are the links between investment and productivity growth? How will #AI impact productivity? Chris Bradley, Jan Mischke, and Marc Canal give an inside look at the McKinsey Global Institute's new report in this interview. ⬇️
A new McKinsey look at the role of productivity in sustainable growth
mckinsey.dsmn8.com
To view or add a comment, sign in
-
With a clear understanding of business objectives and meticulous diligence in implementation, a digital twin can unlock new realms of possibilities. The emergence of generative AI, with its ability to analyze vast quantities of structured and unstructured data and generate insights via user-friendly interfaces, promises to supercharge the promise even more. If your company has a complex problem that is holding back performance, the technology is well worth your consideration.
Digital twins: When and why to use one
mckinsey.dsmn8.com
To view or add a comment, sign in
-
Gen AI agents are AI-powered software entities that plan and perform tasks or aid humans by delivering specific services on their behalf. So far, adoption has faced difficulties because of data quality, employee distrust, and cost of implementation. As gen AI technologies progress and the next gen of agents emerge, we expect more use cases to be unlocked to transform work. Learn the reality of gen AI agents in the enterprise:
The promise and the reality of gen AI agents in the enterprise
mckinsey.dsmn8.com
To view or add a comment, sign in
-
💡Vaccines play a vital role in saving millions of lives each year globally. In this new article, my McKinsey colleagues propose five actions vaccine ecosystem stakeholders could take to leverage pandemic-driven momentum, accelerate vaccine innovation, and address global health challenges: ☑ Expand R&D and manufacturing partnerships ☑ Enhance commercial viability through global funding ☑ Boost vaccination rates ☑ Invest in flexible manufacturing capabilities ☑ Advance global regulatory alignment and regulator-innovator collaboration Read the article here: https://lnkd.in/ePnG8t6R #lifesciences #vaccineecosystem #innovation
Beyond the pandemic: The next chapter of innovation in vaccines
mckinsey.dsmn8.com
To view or add a comment, sign in
-
The medical-aesthetics industry has demonstrated remarkable resilience over the past two decades. This new article by my McKinsey colleagues looks at recent market trends in the sector and points to six signs that medical-aesthetics industry may remain resilient over the medium to long term. Read their findings here: https://lnkd.in/eYQKdvyQ #medicalaesthetics #medtech #lifesciences
To view or add a comment, sign in
-
Here is the first healthcare innovator interview of 2024! This conversation is with Dr. Ben Maruthappu, CEO and Founder of Cera, a digital-first home healthcare company. #digitalhealth #homecare #innovation
The people behind healthcare innovation: Interview with Ben Maruthappu, CEO and Founder of Cera
mckinsey.dsmn8.com
To view or add a comment, sign in
-
Great news that we have been honored by TIME and Statista as one of the 'World's Most Sustainable Companies' of 2024!🌍 https://lnkd.in/e7-pRbwG #Sustainability
World’s Most Sustainable Companies of 2024
mckinsey.dsmn8.com
To view or add a comment, sign in